1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Motor neurone disease

Guidance on the use of Riluzole (Rilutek) for the treatment of Motor Neurone Disease

Technology appraisal guidance [TA20] Published date: 23 January 2001

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 Clinical Need and Practice
  • 3 The Technology
  • 4 Evidence
  • 5 Implications for the NHS
  • 6 Further research
  • 7 Implementation
  • 8 Clinical Audit Advice
  • 9 Review of guidance
  • Appendix A: Appraisal Committee members
  • Appendix B: Sources of Evidence
  • Appendix C: Guidance on the use of Riluzole (Rilutek) for the Treatment of Motor Neurone Disease – patient information
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download

Guidance

  • Next

Appendix C: Guidance on the use of Riluzole (Rilutek) for the Treatment of Motor Neurone Disease – patient information

Appendix C: Guidance on the use of Riluzole (Rilutek) for the Treatment of Motor Neurone Disease – patient information

'Understanding NICE Guidance', a summary of this guidance for patients and carers can be found on our website.


  • Next